Journal of ovarian research

J Ovarian Res · ISSN (e) 1757-2215 · 456 papers in corpus
2026
doi:10.1186/s13048-026-02107-9 ·PMID:42069625

BackgroundThe adnexal region in females presents complex imaging due to the menstrual cycle. Accurate diagnosis is crucial for effective tumor treatment. This study aims to assess the clinical utility of abnormal adnexal uptake on 68Ga-FAPI…

2026
doi:10.1186/s13048-026-02087-w ·PMID:41913264

BACKGROUND: Trends toward earlier age at menarche, the starting point in women’s reproductive lifespan, have been observed globally. Whether an earlier age at menarche influences Anti-Müllerian hormone (AMH), a clinical indicator of ovarian…

2026
doi:10.1186/s13048-026-02036-7 ·PMID:41731522

OBJECTIVE: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder characterized by reproductive and metabolic abnormalities. This study aimed to identify key immunometabolic regulators in endometrial tissue and construct a …

2026
doi:10.1186/s13048-026-02061-6 ·PMID:41917967

BACKGROUND: Polycystic ovary syndrome (PCOS) is a prevalent and heterogeneous endocrine disorder and a leading cause of female infertility. Impaired oocyte maturation in PCOS patients undergoing in vitro fertilization (IVF) adversely affect…

2026
doi:10.1186/s13048-026-01969-3 ·PMID:41652498

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common disorder affecting the reproductive, endocrine, and metabolic systems in women. Dysfunction of granulosa cells (GCs) and imbalance of the immune microenvironment are key pathological …

2026
doi:10.1186/s13048-026-01979-1 ·PMID:41593646

Ovarian cancer remains a highly lethal malignancy, with advanced-stage diagnosis, recurrence, and chemoresistance, thus limiting clinical outcomes. Traditional biomarkers such as CA-125, BRCA1/2 status, and histopathology offer only a parti…

2026
doi:10.1186/s13048-026-02083-0 ·PMID:42092958

BackgroundThe integration of artificial intelligence (AI) into reproductive medicine and gynecologic oncology has driven transformative advances in the diagnosis, prognosis, and management of ovarian conditions, including malignancies, endo…

review 2026
doi:10.1186/s13048-026-01999-x ·PMID:41680866

Female infertility, accounting for 40–50% of infertility cases globally, underscores the urgent need for non-invasive biomarkers to guide early intervention. Cell-free DNA (cfDNA)—released via apoptosis, necrosis, or active secretion—has em…

review 2026
doi:10.1186/s13048-026-02169-9 ·PMID:42298682

Ceramide, a central hub in sphingolipid metabolism, serves as a critical bioactive signalling mediator that integrates lipid metabolism with multiple signalling pathways, primarily promoting autophagy and apoptosis. It influences female rep…

other 2026
doi:10.1186/s13048-026-02027-8 ·PMID:41692776

BACKGROUND: Ovarian endometriotic cysts represent a prevalent form of endometriosis and are typically identifiable via imaging modalities. Nonetheless, differentiating endometriotic cysts from other benign non-endometriotic ovarian cysts, s…

other 2026
doi:10.1186/s13048-026-01970-w ·PMID:41578317

BACKGROUND: The clinical association between female reproductive disorders, such as endometriosis, polycystic ovary syndrome(PCOS), uterine leiomyoma, and female infertility and psychiatric disorders, such as major depressive disorder(MDD),…

2026
doi:10.1186/s13048-026-01989-z ·PMID:41588542

BACKGROUND: High-grade serous ovarian cancer (HGSOC) is the second most lethal gynecologic malignancy, often diagnosed at a late stage due to the lack of reliable early detection strategies. Currently, there are no specific diagnostic or pr…

case-report 2026
doi:10.1186/s13048-026-02088-9 ·PMID:41957787

OBJECTIVE: This study reports a rare case of mixed ovarian carcinoma composed of squamous cell carcinoma (SCC) and high-grade serous carcinoma (HGSC) arising from endometriosis, and provides a systematic review of the relevant literature. …

article 2026
doi:10.1186/s13048-026-02072-3 ·PMID:42010698

BACKGROUND: Endometriosis is a common cause of infertility and is frequently associated with recurrent implantation failure in assisted reproductive technologies. Impaired endometrial receptivity, mediated by altered transcription factors, …

2026
doi:10.1186/s13048-026-02037-6 ·PMID:41761312

BACKGROUND: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with reproductive, metabolic, and psychological features, often underdiagnosed due to diagnostic inaccuracies and inconsistent knowledge among providers. These gaps hi…

2026
doi:10.1186/s13048-026-02016-x ·PMID:41664118

BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by chronic low-grade inflammation of the ovaries. This disorder of the immune microenvironment is closely related to abnormal follicular development and ovulation disorders. This…

2026
doi:10.1186/s13048-026-02031-y ·PMID:41736063

Premature ovarian insufficiency (POI) is a significant clinical challenge leading to amenorrhea and infertility in young women. While its etiology is complex, recent research has highlighted aberrant protein glycosylation as a novel and cru…

article 2026
doi:10.1186/s13048-026-02035-8 ·PMID:41765894

Early detection of epithelial ovarian cancer (EOC) is hampered by the absence of an ideal serum biomarker. This study aimed to further validate the utility of IgG Gal-ratio in pre-operative diagnosis of ovarian cancer. Serum samples were co…

2026
doi:10.1186/s13048-026-02033-w ·PMID:41742290

BACKGROUND: In vitro maturation (IVM) presents a potential alternative to conventional IVF for special subgroups of infertile couples. Anti-Müllerian Hormone (AMH) is widely regarded as the most robust biomarker for assessing ovarian reserv…

article 2026
doi:10.1186/s13048-026-02094-x ·PMID:41947148

BACKGROUND: Oral contraceptive pills (OCPs) are widely used for symptom control in women with ovarian endometrioma; however, their impact on ovarian reserve and the optimal duration of treatment remain uncertain, particularly for women plan…

2026
doi:10.1186/s13048-026-02006-z ·PMID:41794754

OBJECTIVE: To perform a preliminary, hypothesis-generating evaluation of the association between intraovarian injection of platelet-rich plasma (PRP) combined with peripheral blood mononuclear cells (PBMCs) and ovarian response parameters i…

2026
doi:10.1186/s13048-026-02012-1 ·PMID:42050552

BACKGROUND: There is a clear need for new approaches to help women with low ovarian reserve. A new intervention for women with low ovarian reserve is the intra-ovarian injection of platelet-rich plasma (PRP). It is important to comprehensiv…

2026
doi:10.1186/s13048-025-01961-3 ·PMID:41501838

BACKGROUND: Inflammation has been linked to female fertility, yet its impact on ovarian reserve and response remains unclear. This study investigates the associations between systemic inflammatory markers, ovarian reserve—assessed by anti-M…

2026
doi:10.1186/s13048-026-02039-4 ·PMID:41731586

BACKGROUND: Predicting in vitro fertilization (IVF) pregnancy outcomes is crucial for individualized decision-making. However, due to complex interactions among multiple factors, accurate manual integration and assessment are challenging. T…

2026
doi:10.1186/s13048-026-02017-w ·PMID:41814418

Polycystic ovary syndrome (PCOS) is a common reproductive and metabolic disorder with a complex and yet unresolved etiology. Although ovulation induction therapy can improve ovulatory function, the natural pregnancy rate and pregnancy outco…